Aviragen Therapeutics Stock Price (NASDAQ:AVIR)

Add to My Stocks
$0.58 $0.02 (3.33%) AVIR stock closing price Jul 21, 2017 (Closing)
Prev Close* : $0.60
Market Cap:
Day Low: $0.58
52 Week Low: $0.43
Open: $0.6
Volume: 135525
Day High: $0.6
52 Week High: $2.00

Latest Stock Market News

Latest Articles

Aviragen Therapeutics News - From Partners

AVIR Stockcharts

View AVIR PE ratio, PS ratio stocks charts and compare with peers.
AVIR Chart
Note: Compare Aviragen Therapeutics stock price history with the index and industry peers.

Aviragen Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Aviragen Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

AVIR Industry Peers

Company Price Change (%)
Xenetic Biosciences (XBIO)3.250.3 (10.17%)
Eyegate Pharma (EYEG)1.40.02 (1.45%)
Glaxosmithkline (GSK)42.660.11 (0.26%)
Gilead Sciences (GILD)73.760.34 (0.46%)
Novavax (NVAX)1.480.03 (1.99%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Biocryst Pharma (BCRX)5.410.16 (2.87%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 21, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
Aralez Pharma (ARLZ)1.450.07 (4.61%)
ImmunoGen (IMGN)5.660.24 (4.07%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 21, 2017

Aviragen Therapeutics Inc Stock News - Partner Headlines

Aviragen Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues9.3M24.6M68.7M33.6M0.63M
Net Income-25.4M-19.1M-11M-8.7M-2.73M
Total Operating Expense34.5M40.49M29.1M35.3M3.5M
view Aviragen Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets72.7M79.4M114M84.3M92.95M
Total Liabilities26.5M9.9M27.1M16.1M35.61M
Shareholders Equity46.2M69.5M86.9M68.2M57.33M
view Aviragen Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities9.1M-11.5M3.6M-4.5M-0.57M
Net Cash From (Used By) Operating Activities-14.1M-9.6M-3.3M-13.9M-3.74M
Increase (Decrease) In Prop Plant And Equipment-0.2M0.3M-0.1M-1M-
view Aviragen Therapeutics Inc cashflow statement

Aviragen Therapeutics Stock Message Board

Aviragen Therapeutics stock lost 3.27 %, and the last close price as of 20 Jul, 2017 is 0.6 for AVIR stock. The total market value as denoted by 22.45M for Aviragen Therapeutics, is the market value of the company's outstanding shares. Aviragen Therapeutics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Aviragen Therapeutics is worth a lot, it will most likely be reflected in an inflated Aviragen Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 188461 shares were traded with a closing stock price of 0.6 as of 20 Jul, 2017, as can be seen from Aviragen Therapeutics stock quote. One can view Aviragen Therapeutics stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Aviragen Therapeutics does not pay dividends. Aviragen Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.